,title,source,link,date
2,"Ibuprofen Industry Research Report, Growth Forecast 2030 | SI ...",Argyle Report,news.google.com/articles/CBMidWh0dHBzOi8vd3d3LmFyZ3lsZXJlcG9ydC5jb20vbmV3cy9pYnVwcm9mZW4taW5kdXN0cnktcmVzZWFyY2gtcmVwb3J0LWdyb3d0aC1mb3JlY2FzdC0yMDMwLXNpLWdyb3VwLWJhc2YtaW9sY3AvMzI5OTg3L9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-08
39,"2029년까지 오베티콜산 API 시장 통계, 비즈니스 기회, 경쟁 환경 및 ...",엘뉴스,news.google.com/articles/CBMi8wFodHRwczovL3d3dy5sbmV3cy50di8lRUMlODYlOEMlRUMlOEIlOUQvMjAyOSVFQiU4NSU4NCVFQSVCOSU4QyVFQyVBNyU4MC0lRUMlOTglQTQlRUIlQjIlQTAlRUQlOEIlQjAlRUMlQkQlOUMlRUMlODIlQjAtYXBpLSVFQyU4QiU5QyVFQyU5RSVBNS0lRUQlODYlQjUlRUElQjMlODQtJUVCJUI5JTg0JUVDJUE2JTg4JUVCJThCJTg4JUVDJThBJUE0LSVFQSVCOCVCMCVFRCU5QSU4Qy0lRUElQjIlQkQlRUMlOUYlODEvMTE0MjIwMC_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-04
0,Strong week for Solara Active Pharma Sciences (NSE:SOLARA) shareholders doesn't alleviate pain of three-year loss,Simply Wall St,news.google.com/articles/CBMiqQFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1zb2xhcmEvc29sYXJhLWFjdGl2ZS1waGFybWEtc2NpZW5jZXMtc2hhcmVzL25ld3Mvc3Ryb25nLXdlZWstZm9yLXNvbGFyYS1hY3RpdmUtcGhhcm1hLXNjaWVuY2VzLW5zZXNvbGFyYS1zaGFy0gGtAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvaW4vcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbnNlLXNvbGFyYS9zb2xhcmEtYWN0aXZlLXBoYXJtYS1zY2llbmNlcy1zaGFyZXMvbmV3cy9zdHJvbmctd2Vlay1mb3Itc29sYXJhLWFjdGl2ZS1waGFybWEtc2NpZW5jZXMtbnNlc29sYXJhLXNoYXIvYW1w?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-03
14,Foreign Investment Prospects in India's Pharmaceutical Industry,India Briefing,news.google.com/articles/CBMibmh0dHBzOi8vd3d3LmluZGlhLWJyaWVmaW5nLmNvbS9uZXdzL2ZvcmVpZ24taW52ZXN0bWVudC1wcm9zcGVjdHMtaW4taW5kaWFzLXBoYXJtYWNldXRpY2FsLWluZHVzdHJ5LTI5OTM4Lmh0bWwv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-26
